Fingerprint
Dive into the research topics of 'Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically